Isoform Positions

Isoform Protein Position Transcript Position Chromosomal Position (HG38) Chromosomal Position (HG19)
IC2192565998;65999;66000 chr2:178583030;178583029;178583028chr2:179447757;179447756;179447755
N2AB2028461075;61076;61077 chr2:178583030;178583029;178583028chr2:179447757;179447756;179447755
N2A1935758294;58295;58296 chr2:178583030;178583029;178583028chr2:179447757;179447756;179447755
N2B1286038803;38804;38805 chr2:178583030;178583029;178583028chr2:179447757;179447756;179447755
Novex-11298539178;39179;39180 chr2:178583030;178583029;178583028chr2:179447757;179447756;179447755
Novex-21305239379;39380;39381 chr2:178583030;178583029;178583028chr2:179447757;179447756;179447755
Novex-3NoneNone chr2:Nonechr2:None

Information

  • RefSeq wild type amino acid: S
  • RefSeq wild type transcript codon: AGC
  • RefSeq wild type template codon: TCG
  • Domain: Ig-125
  • Domain position: 60
  • Structural Position: 143
  • Q(SASA): 0.5569
  • Predicted PPI site: N

Reported SAVs

SNV RS
DUET
PolyPhen-2
Condel
Rhapsody
REVEL
MVP
Source
MAF
Disease
Zygosity
Site annotation
mCSM PPI
Predicted PPI site
Comments
AFR
AMR
AMS
ASJ
EAS
EUR
FIN
MDE
NFE
SAS
OTH
S/R rs72646867 -0.112 0.982 N 0.435 0.248 0.0551355673512 gnomAD-2.1.1 4.07E-06 None None None None N None 0 0 None 0 0 None 0 None 0 9E-06 0
S/R rs72646867 -0.112 0.982 N 0.435 0.248 0.0551355673512 gnomAD-4.0.0 6.86384E-07 None None None None N None 0 0 None 0 0 None 0 0 9.01486E-07 0 0

Saturation Mutagenesis

SAV
AlphaMissense (IC)
AlphaMissense Class (IC)
AlphaMissense (N2AB)
AlphaMissense Class (N2AB)
mCSM
mCSM class
PolyPhen-2
PolyPhen-2 Class
Rhapsody
Rhapsody Class
Condel
Condel Score
Site annotation
mCSM PPI
Predicted PPI site
S/A 0.0972 likely_benign 0.0962 benign -0.508 Destabilizing 0.218 N 0.454 neutral None None None None N
S/C 0.143 likely_benign 0.1483 benign -0.252 Destabilizing 0.007 N 0.371 neutral N 0.466696479 None None N
S/D 0.5326 ambiguous 0.5621 ambiguous 0.016 Stabilizing 0.967 D 0.406 neutral None None None None N
S/E 0.6961 likely_pathogenic 0.7197 pathogenic -0.078 Destabilizing 0.893 D 0.409 neutral None None None None N
S/F 0.3349 likely_benign 0.3339 benign -1.096 Destabilizing 0.704 D 0.563 neutral None None None None N
S/G 0.1465 likely_benign 0.1525 benign -0.622 Destabilizing 0.505 D 0.411 neutral N 0.449994578 None None N
S/H 0.4392 ambiguous 0.4602 ambiguous -1.148 Destabilizing 0.906 D 0.462 neutral None None None None N
S/I 0.4934 ambiguous 0.5011 ambiguous -0.331 Destabilizing 0.782 D 0.55 neutral N 0.504079779 None None N
S/K 0.8101 likely_pathogenic 0.8433 pathogenic -0.489 Destabilizing 0.733 D 0.416 neutral None None None None N
S/L 0.1557 likely_benign 0.143 benign -0.331 Destabilizing 0.404 N 0.507 neutral None None None None N
S/M 0.3081 likely_benign 0.302 benign 0.082 Stabilizing 0.991 D 0.457 neutral None None None None N
S/N 0.2486 likely_benign 0.2564 benign -0.212 Destabilizing 0.957 D 0.445 neutral N 0.398581535 None None N
S/P 0.7158 likely_pathogenic 0.7243 pathogenic -0.362 Destabilizing 0.967 D 0.434 neutral None None None None N
S/Q 0.5868 likely_pathogenic 0.6229 pathogenic -0.52 Destabilizing 0.967 D 0.397 neutral None None None None N
S/R 0.7189 likely_pathogenic 0.7644 pathogenic -0.237 Destabilizing 0.982 D 0.435 neutral N 0.452322807 None None N
S/T 0.165 likely_benign 0.1582 benign -0.34 Destabilizing 0.505 D 0.459 neutral N 0.490995838 None None N
S/V 0.3996 ambiguous 0.4098 ambiguous -0.362 Destabilizing 0.404 N 0.493 neutral None None None None N
S/W 0.4916 ambiguous 0.5051 ambiguous -1.061 Destabilizing 0.991 D 0.663 neutral None None None None N
S/Y 0.2639 likely_benign 0.2636 benign -0.799 Destabilizing 0.04 N 0.332 neutral None None None None N

Titin has multiple isoforms, the longest being the theoretical IC (inferred complete) isoform which contains all 363 in-frame titin exons. Here all isoform positions have been mapped onto the IC sequence, with an exception being the C-terminal of the much shorter novex-3 isoform. This contains the out of frame exon 48 which cannot be mapped to the other isoforms.